| Enhancer ID: | E_02_0684 |
| Species: | human |
| Position : | chr3:119521736-119523736 |
| Biosample name: | |
| Experiment class : | High+Lowthroughput |
| Enhancer type: | Enhancer |
| Disease: | Colitis |
| Pubmed ID: | 32424849 |
| Enhancer experiment: | RT-PCR?qPCR?Western blotting?Flow cytometric |
| Enhancer experiment description: | RNA sequencing re_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x0002_vealed that treatment with galectin-1 increased the expression of CCAAT/enhancer binding protein ? and CD163, but decreased the expression of CD80 on BMDMs. |
| Target gene : | CD80 |
| Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
| Less strong evidence: | RNA-Seq |
| Target gene experiment description: | RNA sequencing re_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x0002_vealed that treatment with galectin-1 increased the expression of CCAAT/enhancer binding protein ? and CD163, but decreased the expression of CD80 on BMDMs. |
| TF name : | -- |
| TF experiment: | RT-PCR?qPCR?Western blotting?Flow cytometric |
| TF experiment description: | RNA sequencing re_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x0002_vealed that treatment with galectin-1 increased the expression of CCAAT/enhancer binding protein ? and CD163, but decreased the expression of CD80 on BMDMs. |
| Enhancer function : | RNA sequencing re_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x0002_vealed that treatment with galectin-1 increased the expression of CCAAT/enhancer binding protein ? and CD163, but decreased the expression of CD80 on BMDMs. |
| Enhancer function experiment: | Immunohistochemical staining |
| Enhancer function experiment description: |
RNA sequencing re_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x0002_vealed that treatment with galectin-1 increased the expression of CCAAT/enhancer binding protein ? and CD163, but decreased the expression of CD80 on BMDMs. |
| SNP ID: | -- |
| GeneName | Pathway Name | Source | Gene Number |
|---|